In Hungary, the price of 348 medicines dropped an average of 8.3% effective May 1. According to the Ministry of Health, the continuous price reductions on the Hungarian pharmaceutical market are as a result of the Pharmaeconomic Act which was introduced in January (Marketletters passim).
In the case of 34 drugs the price reduction exceeded 20%, while 70 medicines saw their prices drop more than 10%. The changes affected antacids, anti-diabetics, antihypertensive and cardiovascular medicines, antibiotics, certain anti-inflammatory drugs and antidepressants.
First time drug spending kept under control since fall of Communism
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze